Your Space - Health and Fitness

There are three crucial treatments for depression.

The two most import

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ant are psychotherapy and medication therapy.

Psychotherapy aims to r

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

solve any underlying psychic conflicts that may be causing the depresse

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

d state, while also giving emotional support to the patient.

Antidepre

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

sant drugs, by contrast, directly affect the chemistry of the brain, an

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

d presumably achieve their therapeutic effects by correcting the chemic

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

l imbalance that is causing the depression.

The tricyclic antidepressa

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

nt drugs are thought to work by inhibiting the body's physiological ina

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

tivation of the monoamine neurotransmitters. This results in the buildu

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

p or accumulation of these neurotransmitters in the brain and allows th

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

m to remain in contact with nerve cell receptors there longer, thus hel

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ing to elevate the patient's mood.

By contrast, the antidepressant dru

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

gs known as monoamine oxidase inhibitors interfere with the activity of

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

monoamine oxidase, an enzyme that is known to be involved in the collap

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

se of norepinephrine and serotonin.

In cases of severe depression in w

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ich therapeutic results are needed quickly, electroconvulsive therapy h

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

as proven helpful. In this procedure, a convulsion is produced by passi

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

g an electric current through the person's brain. In many cases of trea

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tment, the best therapeutic results are obtained by using a combination

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

of psychotherapy with medication therapy or with electroshock treatment

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.yourspace.org.ua/article/239388/yourspace-Three-Crucial-Treatments-For-Depression.html">Three Crucial Treatments For Depression</a>

BB link (for phorums):
[url=http://www.yourspace.org.ua/article/239388/yourspace-Three-Crucial-Treatments-For-Depression.html]Three Crucial Treatments For Depression[/url]

The most valuable asset to any business are your customers. The relationship between a supplier and a customer is the lifeline of your business.

There comes a time in everyone's life when age starts to creep up on us. As we grow older, most people wake a little stiffer in the morning and experience typical aches and pains, but how do you know if it's arthritis that's troubling you? Knowing how to identify an arthritis symptom can take a load of worry off your mind.

Tags

Links

Your Space - Three Crucial Treatments For Depression

Related Articles: